# BENZONATATE
> **ANDA220298** · Abbreviated New Drug Application (Generic) · Sponsor: MARKSANS PHARMA · Approved 2026-03-30
## Drug
- **FDA Application Number:** ANDA220298
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BENZONATATE
- **Generic name:** BENZONATATE 100 MG
- **Active ingredients:** BENZONATATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MARKSANS PHARMA
- **Manufacturer:** MARKSANS PHARMA LIMITED
- **First approval:** 2026-03-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220298)
---
*MORVS · CC0 1.0*